Comparison Between Atorvastatin and Rosuvastatin on AntiThrombogenic Effect in Patients with Hyperlipidemia
Journal Title: Journal of Enam Meical College - Year 2018, Vol 8, Issue 3
Abstract
Background: Atorvastatin and rosuvastatin are two widely used HMG-CoA reductase inhibitors (statins). These are used as lipid-lowering drugs to reduce atherosclerosis-induced cardiovascular events. The benefcial effects of statins also involve some lipid-independent mechanisms which include modifcation of thrombus formation and degradation, alteration in inflammatory response, plaque stabilization and improvement of endothelial function. Objective: To compare antithrombogenic effect of atorvastatin and rosuvastatin in patients with hyperlipidemia. Materials and Methods: A prospective, open-labeled, interventional, randomized and single-center study was carried out in Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka from March, 2016 to August, 2017 on 52 hyperlipidemic patients. After randomization patients were assigned to atorvastatin 10 mg or rosuvastatin 5 mg daily for 8 weeks. Blood was collected at baseline and after intervention to measure platelet count, prothrombin time (PT) and serum lipid profle. Results: The baseline characteristics of patients treated with atorvastatin and rosuvastatin were almost identical. The platelet count in atorvastatin group was reduced after intervention (2.30%, p=0.463) which was not signifcant but in rosuvastatin group platelet count reduced signifcantly (12.33%, p=0.021) after intervention. There was no statistically signifcant difference (p=0.187) between the two statin treated groups. PT was increased signifcantly after intervention in both atorvastatin group (31.44%, p<0.001) and in rosuvastatin group (31.93%, p=0.003), which was statistically signifcant. No signifcant difference was observed between the two groups (p=0.573). Both atorvastatin and rosuvastatin signifcantly improved serum lipid profle. Conclusion: The present study reveals that rosuvastatin reduced thrombogenesis more effectively than atorvastatin in hyperlipidemic patients.
Authors and Affiliations
Samia Haque Tonu, Jesmine Fauzia Dewan, Fahmida Hasnat, Begum Rudaba Jahan
Keywords
Related Articles
- EP ID EP36313
- DOI https://doi.org/10.3329/jemc.v8i3.38365
- Views 277
- Downloads 0
Primary Nongestational Choriocarcinoma of the Ovary
Pure primary ovarian choriocarcinoma is an extremely rare and aggressive tumor. It can be of gestational or nongestational in origin. The gestational type can arise from an ovarian pregnancy or can be of metastatic ori...
Isolation and Identification of Pathogenic Gram-Positive Bacteria from Egg Shell of Hen and to See Their Antimicrobial Susceptibility Pattern
Background: Food-borne disease is a major public health problem affecting developed as well as developing countries. Inaccurately treated eggs can be one of its causes. So we designed this study to observe the possibil...
Outcomes following Purely Endoscopic Endonasal Resection of Pituitary adenomas
Background: The use of endoscope for the management of pituitary adenoma is not new. The better magnification and illumination provided by the endoscope gives better outcome than microscopic pituitary surgery. Objectiv...
Exclusive Breastfeeding among Preterm Low Birth Weight Infants at One Month Follow-up after Hospital Discharge
Background: Establishment and maintenance of breastfeeding in preterm low birth weight (PT LBW) neonates after discharge from hospital is challenging and may be affected by multiple factors. We designed this study to fin...
Posterior Knee Pain: An Unusual Cause
The pain around the posterior knee called ‘popliteal fossa’ has been known to be caused by a variety of disease entities. Whatever the causes, the challenge remains in diagnosis. Proper history and clinical examination...